# Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

> **NCT01028768** · PHASE1 · COMPLETED · sponsor: **Nycomed** · enrollment: 36 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** Teduglutide

## Key facts

- **NCT ID:** NCT01028768
- **Lead sponsor:** Nycomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-01
- **Final completion:** 2010-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028768, "Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01028768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*